+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novaliq - logo

Novaliq GmbH is a drug delivery company located in the Heidelberg Technology Park, Germany. They develop innovative pharmaceutical formulations based on semifluorinated alkanes (SFAs). The company currently develops novel ophthalmic and dermatological products as well as solutions for organ preservation, based on the unique physicochemical properties of SFA. The company also provides CyclASol, a non-aqueous formulation containing cyclosporine to treat dry eye syndrome. Novaliq GmbH was founded in 2004.

Ophthalmic Drugs Market Report 2024-2034 - Product Thumbnail Image

Ophthalmic Drugs Market Report 2024-2034

  • Report
  • October 2023
  • 284 Pages
  • Global
From
From
Anterior Uveitis - Pipeline Insight, 2024 - Product Thumbnail Image

Anterior Uveitis - Pipeline Insight, 2024

  • Clinical Trials
  • May 2024
  • 60 Pages
  • Global
From
OTC Dry Eye Drops Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

OTC Dry Eye Drops Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Dry Eye Syndrome Drugs Market 2024-2028 - Product Thumbnail Image

Dry Eye Syndrome Drugs Market 2024-2028

  • Report
  • May 2024
  • 168 Pages
  • Global
From
Dry Eye Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Dry Eye Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
From
Dry Eye Medication Market Report 2024 - Product Thumbnail Image

Dry Eye Medication Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Glaucoma - Pipeline Insight, 2024 - Product Thumbnail Image

Glaucoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 170 Pages
  • Global
From
Loading Indicator